South Korea has developed technology that can greatly extend a sub's range by allowing it to create hydrogen fuel cells on its own, according to a state-run defense research agency.
The Agency for Defense Development (ADD) announced that a new technology developed can generate high-purity hydrogen directly in submarines. High-purity hydrogen may be utilized as a fuel in submarine fuel cells.
Submarines also have problems charging their fuel cells since they are inefficient at storing energy and take a long time to charge. Furthermore, hydrogen may only be charged through different stations.
However, the newly-developed technology lets submarines produce high purity hydrogen autonomously through a fuel reforming method that utilizes methanol as a fuel.
Fuel reforming is a method of converting a chemical structure from the fuel's component and extracting the desired substance during the process.
The ADD stressed that the new technology does not require a separate hydrogen charging station and can reduce charging time, allowing for greater submarine range.


RBI Holds Interest Rates Steady Amid Middle East Tensions and Global Uncertainty
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Tabletop particle accelerator could transform medicine and materials science
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Energy Prices and Dollar Climb as U.S.-Iran Conflict Grips Global Markets
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
U.S. Futures Slip as Iran Rejects Ceasefire and Trump Deadline Looms
Asian Currencies Hold Steady as Trump's Iran Deadline Rattles Markets
Gold Prices Drop for Third Consecutive Session Amid Iran Tensions and Inflation Fears
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 



